Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Abemaciclib|DRUG: Standard Adjuvant Endocrine Therapy
Sponsor: Eli Lilly and Company
Collaborators: NSABP Foundation Inc